Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Revue Neurologique
|
June 1, 2005
[Cognitive disorders and falls: experience of the Lille multidisciplinary falls service]
E Maeker, S Bombois, V Pardessus, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 4, 2008
Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease
A Bruandet, F Richard, S Bombois, et al.
Journal of Neuropathology and Experimental Neurology
|
May 3, 2006
Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies
V Deramecourt, S Bombois, C-A Maurage, et al.
Revue Neurologique
|
January 22, 2021
Validation in French of the Montreal Cognitive Assessment 5-Minute, a brief cognitive screening test for phone administration
K Dujardin, S Duhem, N Guerouaou, et al.
Neurology
|
November 27, 2009
Prediction of pathology in primary progressive language and speech disorders
V Deramecourt, F Lebert, B Debachy, et al.
Bulletin De L'Academie Nationale De Medecine
|
April 24, 2020
[Toward a preventive management Alzheimer's disease]
B Dubois, S Bombois, N Villain, et al.
Revue Neurologique
|
August 14, 2025
Amyloid PET imaging in France: One-year experience and perspectives
A Verger, P Payoux, S Heyer, et al.
Translational Stroke Research
|
October 17, 2017
Hippocampal Deformations and Entorhinal Cortex Atrophy as an Anatomical Signature of Long-Term Cognitive Impairment: from the MCAO Rat Model to the Stroke Patient
C Delattre, C Bournonville, F Auger, et al.
Revue Neurologique
|
July 14, 2009
[Biological markers in Alzheimer disease: what are the chances for less slow diagnosis?]
S Schraen-Maschke, C M Dhaenens, S Bombois, et al.
Neurobiology of Disease
|
February 29, 2024
The free plasma amyloid Aβ<sub>1</sub><sub>-</sub><sub>42</sub>/Aβ<sub>1</sub><sub>-</sub><sub>40</sub> ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Aβ<sub>1</sub><sub>-</sub><sub>42</sub>/Aβ<sub>1</sub><sub>-</sub><sub>40</sub> ratio. The BALTAZAR study
S Schraen-Maschke, A Duhamel, J S Vidal, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Revue Neurologique
|
June 1, 2005
[Cognitive disorders and falls: experience of the Lille multidisciplinary falls service]
E Maeker, S Bombois, V Pardessus, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 4, 2008
Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease
A Bruandet, F Richard, S Bombois, et al.
Journal of Neuropathology and Experimental Neurology
|
May 3, 2006
Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies
V Deramecourt, S Bombois, C-A Maurage, et al.
Revue Neurologique
|
January 22, 2021
Validation in French of the Montreal Cognitive Assessment 5-Minute, a brief cognitive screening test for phone administration
K Dujardin, S Duhem, N Guerouaou, et al.
Neurology
|
November 27, 2009
Prediction of pathology in primary progressive language and speech disorders
V Deramecourt, F Lebert, B Debachy, et al.
Bulletin De L'Academie Nationale De Medecine
|
April 24, 2020
[Toward a preventive management Alzheimer's disease]
B Dubois, S Bombois, N Villain, et al.
Revue Neurologique
|
August 14, 2025
Amyloid PET imaging in France: One-year experience and perspectives
A Verger, P Payoux, S Heyer, et al.
Translational Stroke Research
|
October 17, 2017
Hippocampal Deformations and Entorhinal Cortex Atrophy as an Anatomical Signature of Long-Term Cognitive Impairment: from the MCAO Rat Model to the Stroke Patient
C Delattre, C Bournonville, F Auger, et al.
Revue Neurologique
|
July 14, 2009
[Biological markers in Alzheimer disease: what are the chances for less slow diagnosis?]
S Schraen-Maschke, C M Dhaenens, S Bombois, et al.
Neurobiology of Disease
|
February 29, 2024
The free plasma amyloid Aβ<sub>1</sub><sub>-</sub><sub>42</sub>/Aβ<sub>1</sub><sub>-</sub><sub>40</sub> ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Aβ<sub>1</sub><sub>-</sub><sub>42</sub>/Aβ<sub>1</sub><sub>-</sub><sub>40</sub> ratio. The BALTAZAR study
S Schraen-Maschke, A Duhamel, J S Vidal, et al.
Page
of 3